Abstract:Molecular engineering for multifunctional fluorophores (namely BTA and BTB) is presented based on a characteristic electron donor‐π‐acceptor architecture. BTA emits bright near‐infrared II fluorescence and demonstrates remarkable mitochondria‐targeting features and exceptional phototherapy properties to suppress cancer cells both in vitro and in vivo. Importantly, the molecular mechanisms of the phototherapies are elucidated by inducing synergistic cell apoptosis and pyroptosis. Conventional photosensitizers for tumor phototherapy are greatly limited by their reliance on a single‐cell death process, leading to insufficient therapeutic effects and restricted biomedical applications. To address these limitations, multifunctional fluorophores, BTA and BTB, are designed based on an electron donor‐π‐acceptor system. By adjusting the strength of the intramolecular charge transfer through varying electron‐donating moieties, their optical properties are tailored. BTA emits bright near‐infrared II (NIR‐II) fluorescence and exhibits typical aggregation‐induced emission (AIE) characteristics, a large Stokes shift (>250 nm), good photostability, satisfactory biocompatibility, and remarkable mitochondria‐targeting capabilities. Notably, it demonstrates potent photodynamic and photothermal properties. BTA as an effective photosensitizer and a photothermal agent, generates various cytotoxic Type I and II reactive oxygen species and photothermal energy to effectively destroy tumor cell mitochondria and suppress tumor growth. Importantly, the molecular mechanisms underlying combination phototherapy are elucidated, revealing that it induces synergistic cell apoptosis and pyroptosis. These results highlight the potential of multifunctional AIE materials with bright NIR‐II fluorescence and mitochondria‐targeting characteristics for the synergistic phototherapy of breast tumors, offering new insights for future therapeutic developments.

Benzothiazolium‐based NIR AIE photosensitizers with type I and II ROS generation for efficient mitochondria‐targeted photodynamic therapy

Unusual Electron Donor-Acceptor Sequenced NIR AIEgen for Highly Efficient Mitochondria-Targeted Cancer Cell Photodynamic Therapy.

Efficient NIR-II Type-I AIE Photosensitizer for Mitochondria-Targeted Photodynamic Therapy through Synergistic Apoptosis-Ferroptosis

Near-infrared AIEgens with high singlet-oxygen yields for mitochondria-specific imaging and antitumor photodynamic therapy

Novel Naphthalimide Bridged Zinc Porphyrin/bodipy Nanomaterials with D-A Structure for Photodynamic Therapy

A Mitochondria‐Targeted Photosensitizer for Combined Pyroptosis and Apoptosis with NIR‐II Fluorescence/Photoacoustic Imaging‐Guided Phototherapy

Dual-targeted and viscosity-sensitive infrared AIE photosensitizer based on tumor microenvironmental response for photodynamic cancer therapy

Boost Highly Efficient Singlet Oxygen Generation and Accelerate Cancer Cell Apoptosis for Photodynamic Therapy by Logically Designed Mitochondria Targeted Near-Infrared AIEgens

Type I Photosensitizer Based on AIE Chromophore Tricyano-Methylene-pyridine for Photodynamic Therapy

Rationally designed near-infrared AIEgens photosensitizer for cell membrane-targeted photo-driven theranostics

Efficient type I and type II ROS generated aggregation-induced emission photosensitizer for mitochondria targeted photodynamic therapy

Optimizing Mitochondrial-Targeting Groups of Positively-Charged BODIPY Nanoparticles for Enhanced Photodynamic Therapy

Molecular Engineering of Plasma Membrane and Mitochondria Dual‐Targeted NIR‐II AIE Photosensitizer Evoking Synergetic Pyroptosis and Apoptosis

A targeted phototheranostic agent with strong AIE effect and boosted type I ROS generation

Near-infrared AIE-active phosphorescent iridium(III) complex for mitochondria-targeted photodynamic therapy

An AIE-active type I photosensitizer based on N,N′-diphenyl-dihydrophenazine for high-performance photodynamic therapy under hypoxia

Near‐Infrared II AIE Luminogens with Mitochondria‐Targeting Characteristics for Combinational Phototherapies of Breast Tumors Through Synergistic Cell Apoptosis and Pyroptosis

Aggregation-induced emission-active iridium (III)-based mitochondria-targeting nanoparticle for two-photon imaging-guided photodynamic therapy

Biotin Receptor and Mitochondria Dual Targeted AIE Photosensitizer for Fluorescence Imaging Guided Photodynamic Anticancer Therapy

Toward Type I/II ROS Generation Photoimmunotherapy by Molecular Engineering of Semiconducting Perylene Diimide

Donor-Acceptor Modulating of Ionic AIE Photosensitizers for Enhanced ROS Generation and NIR-II Emission